deutsch | english

• Company
• Amnestix
• CNS Program
• Investor Relations
• News and Media
• Contact

SYGNIS Pharma AG

SYGNIS is a specialty pharma company that pioneers innovative therapies for disorders of the Central Nervous System (CNS), in particular of the brain.

Latest Press Releases...

• Aug 12, 2010 : SYGNIS announces three months results of fiscal year 2010/2011
  
• Jun 29, 2010 : Press Release for Annual Report 2010
  

Latest Ad-Hocs...

• 2009/10/19 : SYGNIS secures up to € 10 Million through a 3 year Standby Equity Distribution Agreement with Yorkville